Description

Cultrex®RatCollagenI,LowerViscosityispurifiedfromrattailtendons and isprovidedatastandard concentrationthatislowerinviscosity,makingiteasiertoworkwith.CollagenIisthemajorstructuralcomponentofextracellularmatrices(ECM)foundinconnectivetissueandinternalorgans,butismostprevalentinthedermis,tendons,andbone.Itisa300kDamoleculecomposedoftwoalpha1(I)chainsandonealpha2(I)chainthatspontaneouslyformsatriplehelixscaffoldataneutralpHand37°C.Thisphenomenoncanbeexploitedtopromotecellattachment,growth,differentiation,migration,andtissuemorphogenesisduringdevelopment.ToprovidethemoststandardizedCollagenI,aspecialprocessisemployedtoprovidematerialatastandardconcentrationofapproximately3mg/ml.

Cultrex®RatCollagenI,LowerViscosityisapurifiedstromal ECMprotein thathasbeendeveloped,producedandqualifiedatalowviscosityforgeneralcellcultureapplications.

Qualitycontrolspecifications:

• Nobacterialorfungalgrowthdetectedafterincubationat37°Cfor14daysfollowingUSPsterilitytestingguidelines.
• Endotoxinconcentration≤20EU/mlbyLimulusAmoebocyteLysate(LAL)assay.
• NomycoplasmacontaminationdetectedbyPCR.
• Proteinconcentrationof3mg/ml.
• Providedin 20mMAceticAcid,pH3.4–3.6.
• CollagenIformsagelwhendilutedto0.4mg/mlatneutralpH.
• BIOLOGicalactivitydeterminedforeachlot:
  • CellAttachment:TestedfortheABIlitytopromotecellattachmentandspreADIngofHT1080humanfibrosarcomacells.

Trevigen公司位于美国马里兰州的高科技走廊，是一家有12年历史、成长迅速的生物技术公司，其产品和技术的发展方向主要在癌症研究领域，重点强调细胞凋亡、DNA损伤和修复，以及癌症细胞功能和行为。Trevigen品牌的分销商遍及北美，欧洲和环太平洋地区。关于DNA的损伤分析技术的研究，Trevigen获得美国国立卫生研究院（NIH）的SBIR项目资助。